BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 17784885)

  • 1. Prostatic involvement by urothelial carcinoma of the bladder: clinicopathological features and outcome after radical cystectomy.
    Ayyathurai R; Gomez P; Luongo T; Soloway MS; Manoharan M
    BJU Int; 2007 Nov; 100(5):1021-5. PubMed ID: 17784885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transitional cell carcinoma involving the prostate with a proposed staging classification for stromal invasion.
    Esrig D; Freeman JA; Elmajian DA; Stein JP; Chen SC; Groshen S; Simoneau A; Skinner EC; Lieskovsky G; Boyd SD; Cote RJ; Skinner DG
    J Urol; 1996 Sep; 156(3):1071-6. PubMed ID: 8709310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of patients undergoing radical cystoprostatectomy for bladder cancer with prostatic involvement on final pathology.
    Barocas DA; Patel SG; Chang SS; Clark PE; Smith JA; Cookson MS
    BJU Int; 2009 Oct; 104(8):1091-7. PubMed ID: 19389006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for urothelial carcinoma of the prostate in patients undergoing radical cystoprostatectomy for bladder cancer.
    Patel SG; Cookson MS; Barocas DA; Clark PE; Smith JA; Chang SS
    BJU Int; 2009 Oct; 104(7):934-7. PubMed ID: 19338554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urothelial carcinoma in the prostatic urethra and prostate: current controversies.
    Liedberg F; Chebil G; Månsson W
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):383-90. PubMed ID: 17338657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prostatic involvement by urothelial carcinoma in patients with bladder cancer and their implications in the clinical practice].
    Huguet J
    Actas Urol Esp; 2012 Oct; 36(9):545-53. PubMed ID: 22520044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dilemmas in the treatment of urothelial cancers of the prostate.
    Walsh DL; Chang SS
    Urol Oncol; 2009; 27(4):352-7. PubMed ID: 18439852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis of seminal vesicle involvement by transitional cell carcinoma of the bladder.
    Daneshmand S; Stein JP; Lesser T; Quek ML; Nichols PW; Miranda G; Cai J; Groshen S; Skinner EC; Skinner DG
    J Urol; 2004 Jul; 172(1):81-4. PubMed ID: 15201742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prostatic tumor relapse in patients with superficial bladder tumors: 15-year outcome.
    Herr HW; Donat SM
    J Urol; 1999 Jun; 161(6):1854-7. PubMed ID: 10332452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic involvement by transitional cell carcinoma in patients with bladder cancer and its prognostic significance.
    Shen SS; Lerner SP; Muezzinoglu B; Truong LD; Amiel G; Wheeler TM
    Hum Pathol; 2006 Jun; 37(6):726-34. PubMed ID: 16733214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The risk factor for urethral recurrence after radical cystectomy in patients with transitional cell carcinoma of the bladder.
    Cho KS; Seo JW; Park SJ; Lee YH; Choi YD; Cho NH; Yang SC; Hong SJ
    Urol Int; 2009; 82(3):306-11. PubMed ID: 19440019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
    Lughezzani G; Sun M; Jeldres C; Alasker A; Budäus L; Shariat SF; Latour M; Widmer H; Duclos A; Jolivet-Tremblay M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Feb; 75(2):376-81. PubMed ID: 20022091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prediction of prostatic involvement by urothelial carcinoma in radical cystoprostatectomy for bladder cancer.
    Mazzucchelli R; Barbisan F; Santinelli A; Scarpelli M; Galosi AB; Lopez-Beltran A; Cheng L; Kirkali Z; Montironi R
    Urology; 2009 Aug; 74(2):385-90. PubMed ID: 19501882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The presence of lymphovascular invasion in radical cystectomy specimens from patients with urothelial carcinoma portends a poor clinical prognosis.
    Canter D; Guzzo T; Resnick M; Magerfleisch L; Sonnad S; Bergey M; Tomazewski J; Vaughn D; Van Arsdalen K; Malkowicz B
    BJU Int; 2008 Sep; 102(8):952-7. PubMed ID: 18485042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urothelial carcinoma of the bladder with transmural and direct prostatic stromal invasion: does extent of stromal invasion significantly impact patient outcome?
    Oliva IV; Smith SL; Chen Z; Osunkoya AO
    Hum Pathol; 2011 Jan; 42(1):51-6. PubMed ID: 20870265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of new AJCC exclusion criteria for subepithelial prostatic stromal invasion from pT4a bladder urothelial carcinoma.
    Patel AR; Cohn JA; Abd El Latif A; Miocinovic R; Steinberg GD; Paner GP; Hansel DE
    J Urol; 2013 Jan; 189(1):53-8. PubMed ID: 23164389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer?
    Barbisan F; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Cheng L; Kirkali Z; Montironi R
    BJU Int; 2009 Apr; 103(8):1058-63. PubMed ID: 19076141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Can the prostatic capsule be preserved during cystectomy for bladder tumors: a study of urethral and prostatic involvement in the cystectomy specimens].
    Plante P; Lesourd A; Blanchet P; Castagnola C; Coloby P; Daffer N; Davin JL; Desgrandchamps F; Irani J; Marechal JM; Mottet N; Pariente JL
    Prog Urol; 1998 Feb; 8(1):47-50. PubMed ID: 9533151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy of transurethral biopsy for predicting the long-term clinical impact of prostatic invasive bladder cancer.
    Donat SM; Wei DC; McGuire MS; Herr HW
    J Urol; 2001 May; 165(5):1580-4. PubMed ID: 11342921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.